Sage Capital Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.51M Sell
50,638
-95
-0.2% -$11.1K 1.35% 24
2026
Q1
$6.1M Sell
50,733
-143
-0.3% -$16.5K 1.42% 24
2025
Q4
$5.36M Sell
50,876
-219
-0.4% -$20.6K 1.27% 25
2025
Q3
$4.29M Buy
51,095
+39
+0.1% +$3.21K 1.02% 32
2025
Q2
$4.04M Buy
+51,056
New +$4.06M 1% 35
2019
Q1
Sell
-4,753
Closed -$346K 99
2018
Q4
$346K Sell
4,753
-7,722
-62% -$545K 0.26% 63
2018
Q3
$844K Sell
12,475
-563
-4% -$35.9K 0.53% 51
2018
Q2
$755K Buy
13,038
+1,587
+14% +$89.5K 0.53% 49
2018
Q1
$595K Buy
11,451
+13
+0.1% +$702 0.42% 51
2017
Q4
$614K Buy
11,438
+2,632
+30% +$146K 0.4% 56
2017
Q3
$538K Buy
8,806
+12
+0.1% +$728 0.38% 58
2017
Q2
$538K Buy
+8,794
New +$535K 0.4% 57

Other funds holding MRK

Sage Capital Advisors's MRK Position: Q2 2026 in Review

Sage Capital Advisors reduced its Merck (MRK) stake by 0.19% in Q2 2026, selling an estimated $11.1K and leaving 50,638 shares worth $6.51M. The position accounts for 1.35% of the portfolio, ranked #24.

Sage Capital Advisors first reported a position in MRK in Q2 2017 and has held it in 12 quarters since. 1,299 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Sage Capital Advisors held 50,638 shares of Merck worth $6.51M as of Q2 2026.
  • Sage Capital Advisors sold 95 Merck shares in Q2 2026, an estimated $11.1K.
  • Merck made up 1.35% of Sage Capital Advisors's portfolio in Q2 2026, its #24 holding.
  • Sage Capital Advisors first reported a position in Merck in Q2 2017 and has held it in 12 quarters since.
  • 1,299 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Sage Capital Advisors's 13F filing for Q2 2026, filed 9 Jul 2026.